Elevated plasma NT-proBNP levels are documented in multiple malignancies including lung cancer [49], multiple myeloma [50], neuroendocrine tumor [51], metastatic gastrointestinal stromal tumors (GIST) [52] and breast cancer [53–55]. Here, NPPB is linked to lung carcinoma.